Amyris, Inc. (Emeryville, Calif.) said it will acquire Oobli Inc. (Davis, Calif.), a sweet protein developer whose fermentation-based ingredients help food and beverage brands cut sugar without sacrificing taste. The vertically integrated biomanufacturing company described the move as a commercial and technology expansion that accelerates its presence in protein- and peptide-based solutions across end markets.
Oobli has spent about a decade refining a fermentation process for sweet proteins that occur naturally in rare fruits and berries grown near the equator. Its commercial portfolio covers Oubli Fruit, Serendipity Berry and Katemfe Fruit sweet proteins — scientifically brazzein, monellin and thaumatin — which the company says are the first of their kind in the sugar-reduction category.
Sweet proteins are hundreds to thousands of times sweeter than sugar and bind directly to sweet taste receptors, according to Oobli. Because the body metabolizes them as protein, the company says they deliver sweetness without gut disruption or blood sugar spikes. The ingredients hold FDA GRAS status and are FEMA GRAS-affirmed for use as a natural flavor.
Manufacturing scale behind the deal
The logic of the deal rests on pairing Oobli's protein fermentation expertise with Amyris' strain engineering, manufacturing depth and commercial reach. Earlier this year Amyris expanded capacity at its advanced fermentation facility in Barra Bonita, Brazil, an investment the company presents as the base for supplying protein- and peptide-based products at commercial scale.
Amyris chief executive officer Kathy Fortmann described Oobli as a commercial and technology platform that complements the company's own, and said combining the two could broaden its capabilities in food and beverage, personal care, flavors and fragrances, and agriculture.
Oobli's existing portfolio of sweet proteins is expected to be the first to benefit from the combined platform.
Where the ingredients fit
The companies point to growing consumer awareness of metabolic health as the demand driver. Sweet proteins, they say, give brands a way to lower sugar across sports and nutrition products, dairy, beverages, chocolate, bakery and confectionery.
Oobli chief executive officer Ali Wing said the company had long believed there was a better way to deliver the sweet taste consumers want without trade-offs to health or the environment, and that joining Amyris gives it the scale and resources to pursue its ambition of making sweet proteins a standard sweetness solution.
Fortmann said Amyris has found that biomanufactured solutions succeed when they align with consumer demand and market needs, and that Oobli's platform addresses sweet taste, sugar reduction and clean label at the same time.
Timing and continuity
The acquisition is expected to close in the coming weeks. Amyris said all existing customer commitments and brand partnerships will continue to be honored without interruption as the Oobli portfolio expands inside the company.
